Document is current
Any future updates will be listed below
-
Authors
Wang, Yinghui
Yuan, Jiahao
Wen, Ya
Li, Siyuan
Tian, Lei
Jie, Ying
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2400093427 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Clinical observation of esculin and digitalisglycosides eye drops with 0.3% sodium hyaluronate eye drops for dry eye disease: a randomized controlled trial
https://doi.org/10.1038/s41598-025-90074-4
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82171101)
Beijing Natural Science Foundation (7242019)
Capital Health Research and Development of Special Fund (2024-2-1082)
Beijing Nova Program (H020420160130)
Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes (PWD&RPP-MRI, JYY2023-6)
- License Information
-
More Information
Article History
Received: 26 October 2024
Accepted: 10 February 2025
First Online: 17 February 2025
Declarations
:
: The authors declare no competing interests.
: The research was conducted in compliance with the Declaration of Helsinki, the Good Clinical Practices Standards. It was approved by the Medical Ethics Committee of Beijing Tongren Hospital, Capital Medical University (ethics number: TREC2022-118) and was registered with the Chinese Clinical Trial Registry in 30/05/2023 (ChiCTR2300071953). Before the study began, informed consent was obtained from all participants.
